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Hodgkin lymphoma (HL) is a hematologic malignancy of the lymphoid tissue that
mainly affects young adults.1 Standard treatment for subdiaphragmatic stages I and
II combines chemotherapy regimen followed by dose-reduced involved-field
irradiation (including mediastinum). Adverse effects of treatment include early
death, second neoplasm, and organ dysfunction.1 The consequences of HL
treatments on thymus involution remain poorly explored.2 Here, we investigated the
long-term effects of thymic irradiation on the naive T-cell compartment in 30
patients with HL, 7 to 19 years after mediastinal radiotherapy (all in complete
remission of Hodgkin disease), compared with 60 age- and sex-matched healthy
controls (HCs) (summarized in Table E1 in this article's Online Repository at
www.jacionline.org [21]). Lymphocyte distribution was analyzed by using
fluorescence-activated cell sorting, and thymic output was analyzed by measuring
(1) T-cell receptor excision circles (TRECs) and (2) the frequency of naive thymic
CD4+ CD45RA+ CD31+ T cells, which have higher TREC levels than do peripherally
expanded CD4+ CD31− central T cells3 and 4 (see this article's Methods section in
the Online Repository at www.jacionline.org [21]).
Results showed that the CD3+ and CD3+ TCRαβ+ T-cell counts were significantly
reduced in patients with HL than in matched HCs (P = .02 and P = .01,
respectively), while the total lymphocyte counts were similar in both populations (
Fig 1, A, and Table I). The CD4+ T-cell counts were dramatically lower in patients
than in HCs (P < .001; mean decrease of 32%) while the CD8+ T-cell counts were
equivalent in both groups. Patients with HL exhibited (1) an increase in B-cell
counts (P = .01), with a decreased frequency of memory B cells, indicating an
increase in naive B-cell counts, and (2) a marginal increase in natural killer cell
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